English | Español

Merck
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Press release submission | Sep 23, 2019

MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care
Press release submission | Aug 18, 2018

MERCK: Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes Management
Carol Ostrow | May 16, 2018

FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns | Jan 17, 2018

FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow | Oct 15, 2017

Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow | Oct 1, 2017

Merck to host meeting on third-quarter performance

Trending
Patient Daily | Jul 15, 2025

Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating
Patient Daily | Jul 15, 2025

Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating
+ Pharmaceuticals
Patient Daily | Jul 21, 2025

Executive director of COA on 340B abuse: ‘Imagine using cancer patients as a source of revenue’
+ Pharmaceuticals
Patient Daily | Jul 15, 2025

Baylor College adds two new trustees with extensive leadership experience